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ER stressBackground & aims: Endoplasmic reticulum (ER) stress is associated with development of steatohepatitis. Phos-
phatidylethanolamine N-methyltransferase (PEMT) is a hepatic enzyme located on the ER and mitochondria-
associated membranes and catalyzes phosphatidylcholine (PC) synthesis viamethylation of phosphatidyletha-
nolamine (PE). We hypothesized that PEMT deﬁciency inmice alters ER phospholipid content, thereby inducing
ER stress and sensitizing the mice to diet-induced steatohepatitis.
Methods: PC and PE mass were measured in hepatic ER fractions from chow-fed and high fat-fed Pemt−/− and
Pemt+/+ mice. Proteins implicated in ER stress and the unfolded protein response (UPR) were assessed in
mouse livers and in McArdle-RH7777 hepatoma cells that expressed or lacked PEMT. The chemical chaperone
4-phenyl butyric acid was administered to cells and HF-fed Pemt−/−mice to alleviate ER stress.
Results: In chow-fed Pemt−/−mice, the hepatic PC/PE ratio in the ERwas lower than in Pemt+/+mice, and levels
of ER stress markers, CHOP and BIP, were higher without activation of the UPR. In livers of HF-fed Pemt−/−mice
the ERhad a lower PC/PE ratio, and exhibitedmore ER stress andUPR activation. Similarly, theUPRwas repressed
in McArdle cells expressing PEMT compared with those lacking PEMT, with concomitantly lower levels of CHOP
and BIP. 4-Phenyl butyric acid attenuated activation of the UPR and ER stress in McArdle cells lacking PEMT, but
not the hepatic ER stress in HF-fed Pemt−/−mice.
Conclusion: PEMT deﬁciency reduces the PC/PE ratio in the ER and induces ER stress, which sensitizes themice to
HF-induced steatohepatitis.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The global incidence of non-alcoholic fatty liver disease (NAFLD) is
rapidly rising as a complication of obesity and diabetes [1–3]. Recent
studies [4,5] have linked NAFLD to a reduced molar ratio of hepatic
phosphatidylcholine (PC) to phosphatidylethanolamine (PE). A de-
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niversity of Alberta, Edmonton,feature of non-alcoholic steatohepatitis patients [5,6]. Moreover, in
mice, the PC/PE ratio strongly predicts liver function and survival after
partial hepatectomy [7]. In mice, ~70% of hepatic PC is synthesized via
the CDP-choline pathway and 30% via the phosphatidylethanolamine
N-methyltransferase (PEMT) pathway [8,9]. Inhibition of either path-
way results in steatosis [10], which is mainly due to decreased hepatic
PC production and impaired very low density lipoprotein secretion
[11]. Mice lacking PEMT develop NASH when fed a high-fat (HF) diet
for 2 weeks [7,12].
The endoplasmic reticulum (ER) is responsible for the synthesis,
folding, trafﬁcking and maturation of proteins, for the synthesis of cho-
lesterol, PC, PE and triacylglycerol and for calciumhomeostasis and drug
metabolism reviewed in [13,14]. ER stress is associated with chronic
syndromes such as obesity, diabetes and fatty liver [15–18]. In response
to ER stress, cells activate the unfolded protein response (UPR) to re-
store the homeostatic equilibrium caused by aberrant protein metabo-
lism [19]. The UPR is mediated by three transducers: protein kinase-
like ER kinase, inositol-requiring enzyme-1 (IRE1) and activating tran-
scription factor 6α (ATF6α) as reviewed [19,20], each of which triggers
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inhibits protein translation and decreases protein production via phos-
phorylation of the eukaryotic initiation factor 2α (eIF2α) [21]. PERK ac-
tivation also increases the pro-apoptotic proteins C/EBP–homologous
protein andGADD34 (growth arrest andDNAdamage-inducible protein
34) [22,23]. IRE1 activation increases the spliced form of X-box binding
protein-1 (XBP1s), which translocates to the nucleus and regulates the
production of ER chaperones and proteins involved in ER-associated
protein degradation [24]. In addition, the cytosolic domain of IRE1 acti-
vates the JNK pathway independently of XBP1s [25]. The third canonical
arm of the UPR involves ATF6αwhich, in response to ER stress, translo-
cates to the Golgi and is cleaved to produce an active form, which mi-
grates to the nucleus and regulates expression of ER chaperones [26].
PEMT is active in the ER and ER-derived mitochondria-associated
membranes [27]. Lack of PEMT leads to a decrease in hepatic PC and ac-
cumulation of hepatic PE [28]. In livers of Pemt−/− mice fed either a
choline-deﬁcient diet or a high-fat diet, PC is reduced and PE is in-
creased resulting in a decreased PC/PE ratio [5,7]. We hypothesized
that the aberrant ER phospholipid composition in livers of Pemt−/−
mice leads to ER stress that sensitizes the liver to HF-induced NASH.
2. Materials and methods
2.1. Animal handling, diets and treatments
All procedures were approved by the University of Alberta's Institu-
tional Animal Care Committee in accordance with guidelines of the
Canadian Council on Animal Care.Male C57BL/6 (backcrossed N7 gener-
ations) Pemt+/+ and Pemt−/−mice (8–9 weeks old) [28] were housed
with free access to water and were fed either a chow diet (LabDiet,
#5001) or a HF diet (Bio-Serv, #F3282). In separate experiments,
Pemt+/+ and Pemt−/− mice were administered 4-phenylbutyric acid
(PBA, Scandinavian Formulas) or vehicle twice daily (total 1 g/kg body
weight/day), by oral gavage during the HF feeding. All micewere fasted
for 12 h before sacriﬁce. Tissues were collected and stored at−80 °C
until analysis or preserved in 10% phosphate-buffered formalin for
histology.
2.2. Cell culture
McArdle RH-7777 rat hepatoma cells stably expressing the pCI vec-
tor (pCI-EmptyMcA) or human PEMT (PCI-PEMTMcA) [29]weremain-
tained in Dulbecco's modiﬁed Eagle's medium (Invitrogen) containing
10% fetal bovine serum (Invitrogen) and geneticin G418 (0.2 mg/ml,
Invitrogen). Cells were cultured in 10 cm dishes at 37 °C in 5% CO2,
90% relative humidity. PEMT activity in PCI-PEMTMcA cells was similar
to that in livers from chow-fed Pemt+/+mice [29]. In someexperiments,
cells were incubated for 24 h ± 1 mM PBA.
2.3. Isolation of ER
The protocol for isolation of ER from mouse liver was adapted from
Croze and Morre [30]. The purity of ER isolated by this method has
been extensively characterized [31]. Brieﬂy, age-matched male Pemt+/
+ and Pemt−/− mice were fed a chow or HF diet for two weeks, then
fasted overnight and anesthetized by isoﬂurane. Livers (~1.0 g) were
immediately dissected and transferred to 10 ml ice-cold homogeniza-
tion buffer (0.5 M sucrose, 1% dextran, 37.5 mM Tris, 5 mM MgCl2,
1 mM dithiothreitol and 0.1 mM phenylmethylsulfonyl ﬂuoride,
pH 7.4). The liver was chopped into small pieces and homogenized
with a polytron for 30 s at 4000 rpm. The homogenate was centrifuged
at 5000 ×g for 15 min and the ER fraction was isolated from the super-
natant by ultracentrifugation on a sucrose gradient (8ml 1.3M sucrose,
8ml 1.5M sucrose, 6ml 2M sucrose). The ERwas collected andwashed
with ice-cold buffer (55mMTris, 5 mMMgCl2, 1 mMdithiothreitol and
0.1 mM phenylmethylsulfonyl ﬂuoride, pH 7.4). After centrifugation at90,000 ×g for 20min, the ER pellet was re-suspended in ice-cold buffer
(0.25 M sucrose, 10 mM Tris, 1 mM dithiothreitol, and 0.1 mM
phenylmethylsulfonyl ﬂuoride, pH 7.4) containing a protease inhibitor
cocktail (Sigma #P8340). The ER fraction was snap-frozen in liquid ni-
trogen for further analysis.
2.4. Analytical procedures
The mass of TG was measured by a commercially available kit from
Roche Diagnostics according to the manufacturer's protocol. Hepatic
PC and PE were isolated by thin-layer chromatography and quantiﬁed
using a phosphorous assay [32]. Plasma alanine aminotransferase was
measured using a commercially available kit (Biotron Diagnostics). He-
patic cytokines and chemokines were quantiﬁed at Eve Technologies
Corp. (Calgary, Alberta) with the Bio-Plex™ 200 system (Bio-Rad Labo-
ratories, Inc., Hercules, CA, USA), a Milliplex TGF-β 3-plex kit (Millipore,
St. Charles, MO, USA) and a Milliplex Mouse Cytokine/Chemokine 32-
plex kit (Millipore, St. Charles, MO, USA) according to the manufac-
turers' protocol. The transforming growth factor-β (TGF-β) 3-plex kit
quantiﬁed TGF-β1, TGF-β2 and TGF-β3. The 32-plex consisted of
Eotaxin, G-CSF (granulocyte colony-stimulating factor), GM-CSF (gran-
ulocyte-macrophage colony-stimulating factor), IFNγ, the interleukins
(IL)-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12
(p70), IL-15, IL-17, IP-10 (IFN-γ-inducible protein 10), KC
(keratinocyte-derived cytokine), LIF (leukemia inhibitory factor), LIX,
MCP (monocyte chemotactic protein)-1, MIG (Chemokine (C-X-C
motif) ligand 9 (CXCL9), macrophage inﬂammatory protein (MIP)-1α,
MIP-1β, MIP-2, RANTES, TNF α, and VEGF (vascular endothelial growth
factor).
2.5. Histology
A portion of the liver was subjected to hematoxylin and eosin
(H&E) staining or Tunel staining. Liver slices stained by H&E were
scored for steatosis, hepatocellular ballooning, portal inﬂammation
and lobular inﬂammation using a modiﬁed NAFLD scoring system
[33]. For Tunel staining, liver slices were stained using APO-BrdU™
TUNEL Assay kit from Life Technologies, following the manufacturer's
instructions.
2.6. Real-time quantitative PCR
Total RNA was isolated from snap-frozen livers using TRIzol reagent
(Invitrogen). Total RNA was treated with DNase I (Invitrogen) then
reverse-transcribed using an oligo(dT)12–18 primer and Superscript II
reverse transcriptase (Invitrogen). Primers for CD 68 (forward: GCG
GCT CCC TGT GTG TCT GAT; reverse: GGG CCT GTG GCT GGT CGT AG),
F4/80 (forward: CCC TCG GGC TGT GAG ATT GTG; reverse: TGG CCA
AGG CAA GAC ATA CCA G), collagen I α1 (COL1A1, forward: CTT CAC
CTA CAG CAC CCT TGT G; reverse: TGA CTG TCT TGC CCC AAG TTC)
and collagen III α1 (COL3A1, forward: TGT CCT TTG CGA TGA CAT AAT
CTG; reverse: AAT GGG ATC TCT GGG TTG GG) were purchased from
the Institute of Biomolecular Design, University of Alberta. mRNA levels
were quantiﬁed by real-time quantitative PCR using a Rotor-Gene 3000
instrument (Montreal Biotech) and normalized to cyclophilin (forward:
TCC AAA GAC AGC AGA AAA CTT TCG; reverse: TCT TCT TGC TGG TCT
TGC CAT TCC) mRNA using a standard curve.
2.7. Immunoblotting
Tissues and cells were homogenized in buffer (25 mM Tris–HCl,
500 mM sucrose, 1 mM EDTA, 1 mM dithiothreitol, and 0.1 mM
phenylmethylsulfonyl ﬂuoride, pH 7.4) containing a protease inhibitor
cocktail, followed by sonication for 10 s. Proteins were electrophoresed
on SDS-polyacrylamide gels and transferred to polyvinylidene
diﬂuoride membranes. The membranes were probed with primary
Fig. 1. Chow-fed Pemt−/−mice exhibit hepatic ER stress and steatosis. (A) H&E staining of liver sections; size bar: 50 μm; and hepatic TG mass. (B) NAFLD scores of liver H&E staining.
(C) Representative immunoblots for proteins implicated in ER stress and the UPR in livers. (D) Densitometric analysis of data in panel (C). (E) Immunoblotting of subcellular markers
in homogenates and ER fractions isolated from mouse livers. Plasma membrane protein Integrin β1; Golgi marker β1,4-galactosyltransferase; ER markers PDI and calnexin; cytosolic
marker α-tubulin; mitochondrial marker UCP2 (uncoupling protein 2). 20 μg of protein was loaded in each lane. (F) Mass of PC and PE and PC/PE molar ratio in hepatic ER. Data are
averages from 3 mice each genotype for panels A–B and 6–7 mice each genotype for panels C, D & F; *P b 0.05, Pemt+/+vs Pemt−/−.
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phospho-PERK (p-PERK, thr980, 1:1000 dilution, #3179), PERK
(1:1000 dilution, #3192), phospho-eIF2α (p-eIF2α, ser51, 1:1000 dilu-
tion, #9721), eIF2α (1:1000 dilution, #9722), IRE1α (1:1000 dilution,
#3294), XBP1s (1:1000 dilution, #12782), CHOP (1:1000 dilution,
#2895), integrin β1 (1:1000 dilution, #4706), α-tubulin (1:1000 dilu-
tion, #2144), phospho-JNK (p-JNK, Thr183/Tyr185, 1:1000 dilution,
#4668), cleaved caspase-3 (1:1000 dilution, #9661), caspase-3
(1:1000 dilution, #9665), cytochrome c (1:1000 dilution, #4272), andBCL-2 (1:1000 dilution, #2876, B-cell lymphoma 2); primary antibodies
against ATF6α (1:1000 dilution, ab11909), phospho-IRE1α (p-IRE1α,
Ser724, 1:1000 dilution, ab48187), and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, 1:1000 dilution, ab8245) were obtained from
Abcam; primary antibodies against protein disulﬁde isomerase (PDI,
1:1000 dilution, SPA-890), glucose-regulated protein 78 (BIP, 1:1000
dilution, SPA-826) and calnexin (1:1000 dilution, SPA-865) were
from Enzo Life Sciences, and primary antibody against Golgi-β1,4-
galactosyltransferase was from Santa Cruz Biotechnology (1:1000
Fig. 2. ER stress in livers of HF-fed Pemt−/−mice. Pemt−/− and Pemt+/+micewere fed the HF diet for 2weeks. (A) Representative immunoblots of proteins implicated in ER stress and the
UPR in liver homogenates. (B) Densitometric analysis of immunoblots from panel (A): protein amount was normalized to the loading control GAPDH and the values were normalized to
those from the corresponding control group. (C)Mass of PC, PE andPC/PEmolar ratio inhepatic ER. (D)Mass of PC, PE andPC/PEmolar ratio inmouse liver homogenates. Data are averages
from 6 to 7 mice each genotype; *P b 0.05, Pemt+/+vs Pemt−/−.
2692 X. Gao et al. / Biochimica et Biophysica Acta 1852 (2015) 2689–2699dilution, sc-22292-R). All primary antibodies were diluted with 5% (w/v)
bovine serum albumin in T-TBS buffer (20 mM Tris–HCl, 150 mM NaCl,
0.1% Tween 20, pH 7.4). Secondary antibodies were goat anti-mouse
and goat anti-rabbit IgG-horseradish peroxidase conjugate (Bio-Rad)
and were diluted 1:5000–1:10,000 with 1% (w/v) skim milk in T-TBS
buffer. The immunoreactive bands were visualized by an enhanced
chemiluminescence system (Amersham Biosciences) according to the
manufacturer's instructions and protein levels were quantiﬁed using
ImageJ software.2.8. Statistical analysis
Data are means ± SEM. Comparisons between two groups were
performed using Student's t-test. For all other comparisons, a two-
way ANOVA, followed by post hoc Bonferroni's test of individual
group differences, was used. P b 0.05 was considered signiﬁcant.3. Results
3.1. ER stress and altered ER phospholipid levels occur in chow-fed
Pemt−/−mice
Chow-fed Pemt−/−mice develop hepatic steatosis and inﬂammation
as indicated by bothH&E staining (Fig. 1A) and histological NAFLD scor-
ing (Fig. 1B), although hepatic TG mass is not signiﬁcantly different be-
tween Pemt genotypes. In Pemt+/+mice, steatosis, portal inﬂammation
and ballooningwere scored as zero. To determine if PEMT deﬁciency in-
duced hepatic ER stress, we measured protein levels of BIP and CHOP
(two markers of ER stress), as well as PDI and calnexin in livers. BIP
and CHOP were signiﬁcantly higher in Pemt−/−mice than in Pemt+/+
mice, whereas PDI and calnexin were comparable in the two genotypes
(Fig. 1C, D). We also quantiﬁed proteins associated with the UPR to de-
termine if the ER stress could be attributed to activation of the UPR.
However, p-PERK, PERK and eIF2α were not increased by PEMT
Fig. 3. ER stress inMcA cells lacking PEMT is alleviated by 4-phenylbutyric acid (PBA). (A)Mass of TG, PC and PE, and PC/PEmolar ratio inMcA cells transfectedwith empty pCI vector (pCI-
Empty) andMcA cells expressing PEMT (pCI-PEMT). (B) Mass of TG in pCI-Empty and pCI-PEMT cells. (C) Representative immunoblots of proteins implicated in ER stress and UPR in pCI-
Empty and pCI-PEMT cells under basal conditions and after treatment with PBA. (D) Densitometric analysis of immunoblots in (C): protein amounts were normalized to the loading
control actin and these values were normalized to those from corresponding control group. *P b 0.05, pCI vs PEMT; #P b 0.05, PBA-treated pCI-Empty vs PBA-treated PCI-PEMT. Data
are averages from three independent experiments.
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niﬁcantly lower in Pemt−/−mice (Fig. 1C, D). In the IRE1 pathway, p-
IRE1α was 69% lower in Pemt−/−mice than in Pemt+/+ mice, whereas
the level of IRE1α was unaffected by Pemt genotype (Fig. 1C, D). The
level of ATF6α was also unaffected by PEMT deﬁciency (Fig. 1C, D).
Thus, chow-fed Pemt−/−mice exhibit hepatic ER stress without activa-
tion of the UPR.
An increased hepatic PC/PE ratio has been associated with ER stress
in obese mice [34]. To determine if ER stress in livers of chow-fed
Pemt−/− mice could have been caused by altered ER phospholipidcomposition we isolated ER from mouse livers. Purity of the isolated
ER was indicated by enrichment of the ER proteins calnexin and PDI in
the ER fraction compared to the homogenate, as well as very low levels
of markers of other cellular compartments in the ER such as
plasma membrane protein β-integrin and Golgi marker Golgi-β1,4-
galactosyltransferase (Fig. 1E). The amount of PC in the ER from livers
of Pemt−/− mice was lower, whereas PE was higher, than in Pemt+/+
mice. Consequently, the PC/PE ratio in hepatic ER from Pemt−/− mice
was signiﬁcantly lower than in Pemt+/+mice (Fig. 1F). Thus, the higher
level of ER stress in livers of chow-fed Pemt−/− mice, compared to
Fig. 4. PBA does not alter body mass, hepatic PC or PE in Pemt+/+ or Pemt−/−mice. Pemt+/+ and Pemt−/−mice were fed the HF diet ± PBA for two weeks. (A) Body weight (B.W.) gain,
initial bodyweight (g) and ﬁnal bodyweight (g). (B)Weight of white adipose tissue in g and as % B.W. (C)Weight of brown adipose tissue in g and as % of B.W. (D)Mass of hepatic phos-
phatidylcholine (PC) and phosphatidylethanolamine (PE) and PC/PEmolar ratio in livers fromHF-fed Pemt+/+ and Pemt−/−mice. Data are from 4 to 7mice of each genotype, *P b 0.05 for
Pemt+/+vs Pemt−/− with the same treatment.
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in the ER.
3.2. PEMT deﬁciency increases sensitivity of the liver to HF-induced
ER stress
To determine if pre-existing ER stress sensitized Pemt−/− livers to
stress induced by a HF diet, we compared levels of proteins involved
in ER stress/UPR in livers of Pemt+/+ and Pemt−/− mice fed the HF
diet for two weeks. Two markers of ER stress (CHOP and PDI) were
higher in HF-fed Pemt−/−mice than in HF-fed Pemt+/+ mice, whereastwo other ER proteins (BIP and calnexin) were not affected by Pemt ge-
notype (Fig. 2A, B). Moreover, the UPR was activated in livers of
Pemt−/− mice: p-PERK, PERK and p-eIF2α were higher in Pemt−/−
mice than in Pemt+/+ mice, whereas the level of IRE1α was not differ-
ent. In addition, p-IRE1α was markedly lower in livers of HF-fed mice
of both genotypes than in chow-fed mice (data not shown). Despite
no difference in the amount of IRE1α, the amount of its downstream
target XBP1s was 34% higher in HF-fed Pemt−/−mice than in Pemt+/+
mice (Fig. 2A, B). Similarly, ATF6α was 50% higher in Pemt−/− mice
than in Pemt+/+ mice (Fig. 2A, B). Importantly, the amount of PC and
the PC/PE molar ratio were also lower in hepatic ER isolated from
Fig. 5. PBA does not reverse NASH but modestly improves steatosis in HF-fed Pemt−/−mice. Pemt+/+ and Pemt−/−mice were fed the HF diet ± PBA for two weeks. (A) Liver weight in g
and as % of bodyweight (B.W.). (B) Plasma alanine aminotransferase (ALT). (C) H&E staining of liver sections andNAFLD scores; size bar: 50 μm. (D) Hepatic TGmass. (E)mRNA levels for
CD68 and F4/80were normalized tomRNA level of cyclophilin and these values were normalized to those from the corresponding control group. (F) Levels of TGFβ1, TGFβ2 and TGFβ3 in
total liver homogenates quantiﬁed by aMilliplex TGF-β 3-plex kit. (G)mRNA levels for collagen Iα1 (COL1A1) and collagen IIIα1 (COL3A1)were normalized tomRNA level of cyclophilin
and these values were normalized to those from the corresponding control group. Data are from 6 to 7 mice each group; *P b 0.05, Pemt+/+vs Pemt−/− (same treatment); #P b 0.05, PBA
treatment vs Vehicle (Veh) for the same genotype.
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the PC/PE molar ratio in liver homogenates were also lower in Pemt−/−
mice than Pemt+/+ mice (Fig. 2D). Thus, upon HF feeding of the mice,
PEMT deﬁciency increases ER stress in the liver and activates the UPR.
3.3. PEMT deﬁciency increases ER stress in McArdle cells
To determine if PEMT deﬁciency increased ER stress in a cell
model, levels of proteins associated with ER stress and the UPRwere assessed in McA cells, a commonly used cell model of hepa-
tocytes. McA cells lack PEMT enzymatic activity [27]. McA cells
were stably transfected with either empty vector (pCI-Empty
McA cells) or human PEMT cDNA (PCI-PEMT McA cells) [29].
Compared to pCI-Empty McA cells, PCI-PEMT McA cells contained
equivalent amounts of cellular PC, but 31% less PE. Consequently,
the PC/PE ratio was 41% lower in pCI-Empty McA cells than in PCI-
PEMT McA cells (Fig. 3A). The amount of TG in pCI-Empty McA
cells was not different from that in PCI-PEMT McA cells
Fig. 6. PBA slightly improves ER stress and decreases apoptosis in HF-fed Pemt−/−mice. Pemt+/+ and Pemt−/−mice were fed the HF diet ± PBA for two weeks. (A) Representative im-
munoblots of proteins implicated in ER stress and the UPR. (B) Densitometric analysis of data from panel A. Data are from 6 to 7 mice in each group; *P b 0.05, Pemt+/+vs Pemt−/− for
the same treatment; #P b 0.05, PBA treatment vs vehicle (Veh) within the same genotype.
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levels of BIP, CHOP and PDI, but not calnexin, were higher in
pCI-Empty McA cells than in PCI-PEMT McA cells (Fig. 3C, D). In
addition, p-PERK was signiﬁcantly higher in pCI-Empty McA
cells than in PCI-PEMT McA cells, whereas PERK, p-eIF2α, and
eIF2α were unaltered by PEMT deﬁciency (Fig. 3C, D). Although
levels of p-IRE1α were comparable in pCI-Empty McA and PCI-
PEMT McA cells, IRE1α and its downstream target XBP1s were
signiﬁcantly higher in the pCI-Empty McA cells (Fig. 3C, D).
ATF6α was not detectable in either pCI-Empty McA or PCI-PEMT
McA cells (data not shown). These results indicate that PEMT de-
ﬁciency in McA cells induces ER stress and activates the UPR.
3.4. PBA alleviates ER stress in McA cells
The chemical chaperone PBA protects primary hepatocytes from
palmitate-mediated ER stress [35]. We, therefore, hypothesized that
PBA might alleviate ER stress in pCI-Empty McA cells that lacked
PEMT. PBA prevented the elevation of IRE1α, XBP1s, BIP and CHOP in
pCI-Empty McA cells (Fig. 3C, D). However, levels of UPR proteins
(PERK, p-eIF2α, eIF2α and p-IRE1α), and the ER chaperone calnexin,
were unaltered by PBA in both pCI-Empty McA cells and PCI-PEMT
McA cells (Fig. 3C, D).
3.5. PBA does not prevent HF-induced NASH in Pemt−/−mice
To determine if PBA attenuated NASH in HF-fed Pemt−/− mice,
we administered PBA to HF-fed Pemt+/+ and Pemt−/−mice accord-
ing to the protocol described in [36]. PBA did not alter body weight
or the mass of brown or white adipose in mice of either Pemt geno-
type (Fig. 4A-C), or the mass of hepatic PC or PE (Fig. 4D). Nor did
PBA prevent hepatomegaly or the increase in plasma ALT in
Pemt−/− mice (Figs. 5A, B). These observations are consistent with
the pathological scoring of the liver sections in which HF-fed
Pemt−/− mice exhibited profound hepatic lipid accumulation, aswell as severe inﬂammation and ballooning, which were not im-
proved by PBA (Fig. 5C). However, PBA slightly, but signiﬁcantly, re-
duced hepatic TG mass in HF-fed Pemt−/−mice (Fig. 5D). Thus, PBA
does not prevent NASH in HF-fed Pemt−/−mice and only slightly re-
duces hepatic TG accumulation.
We also determinedwhether or not PBA attenuatedmacrophage in-
ﬁltration and ﬁbrogenic features in HF-fed Pemt−/−mice. The level of
mRNA encoding the macrophage marker CD68 was higher in vehicle-
treated Pemt−/−mice than in Pemt+/+ mice (Fig. 5E), and PBA did not
prevent this increase. In addition, PBA did not reduce the amount of
F4/80 mRNA in livers of mice of either genotype (Fig. 5E). Livers of
vehicle-treated Pemt−/−mice exhibited ﬁbrogenic features with higher
levels of TGF-β1 and TGF-β2 compared to Pemt+/+ mice, although
PEMT deﬁciency reduced the amount of TGF-β3 (Fig. 5F). We also mea-
sured themRNA levels for collagen I and collagen III in these livers, both
of which were higher in Pemt−/− mice compared to Pemt+/+ mice
(Fig. 5G). PBA did not reduce the amount of any of the TGF-β family
members, or the mRNA levels of collagen I and collagen III in Pemt−/−
or Pemt+/+mice. Thus, we conclude that PBA does not diminishmacro-
phage inﬁltration or ﬁbrogenic features in HF-fed Pemt−/−mice.
3.6. PBA does not reduce ER stress in HF-fed Pemt−/−mice
Since PBA suppresses ER stress in livers of ob/obmice [36], we hy-
pothesized that PBA might also alleviate HF-induced ER stress in livers
of Pemt−/−mice. As shown in (Fig. 6A, B), PEMT deﬁciency caused he-
patic ER stress in HF-fed mice and increased the amounts of CHOP and
p-eIF2α. However, PBA did not signiﬁcantly reduce levels of these pro-
teins in Pemt−/− mice (Fig. 6A, B). We conclude, therefore, that PBA
does not reduce hepatic ER stress or the upregulated UPR in HF-fed
Pemt−/−mice.
Prolonged ER stress can lead to apoptosis [13]. Thus, we determined
if apoptosis were more pronounced in livers of HF-fed Pemt−/− mice
than in Pemt+/+ livers. Indeed, amounts of marker proteins of apoptosis
(cytochrome c and cleaved-caspase 3) were higher in HF-fed Pemt−/−
Fig. 7. PBA decreases apoptosis inHF-fed Pemt−/−mice. Pemt+/+ and Pemt−/−micewere fed theHF diet± PBA for twoweeks. (A) Representative immunoblots of cytochrome c, cleaved
caspase-3, caspase-3, p-JNK, BCL-2 (B-cell lymphoma 2) and loading control GAPDH. (B) Densitometric analysis of immunoblots in (A): protein amounts were normalized to the loading
control GAPDH and these values were normalized to those from corresponding control group. Data are from 6 to 7 mice in each group; *P b 0.05, Pemt+/+vs Pemt−/− for the same treat-
ment; #P b 0.05, PBA treatment vs vehicle (Veh)within the same genotype. (C) Representative Tunnel staining of liver sections: arrows indicate apoptotic cells. Data are from2 to 3mice in
each group.
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unaltered by PEMT deﬁciency (Fig. 7A, B). In HF-fed Pemt−/− mice,
PBA reduced cytochrome c and cleaved-caspase 3 to levels similar
to those in Pemt+/+mice (Fig. 7A, B). However, PBA did not decrease
the amount of the anti-apoptotic protein, BCL-2, or the stress/
inﬂammation-induced transcription factor p-JNK (Fig. 7A, B). More-
over, qualitative Tunel staining revealed apoptosis in livers of HF-
fed Pemt−/−mice compared to Pemt+/+ mice (Fig. 7C). PBA reduced
apoptotic cells in HF-fed Pemt−/−mice (Fig. 7C). Taken together, PBA
reduces apoptosis in livers of HF-fed Pemt−/− mice.
Cytokines are critical mediators of hepatic inﬂammation and play a
fundamental role in the pathophysiology of acute and chronic fatty
liver diseases [37]. We, therefore, compared levels of cytokines and
chemokines in livers of HF-fed Pemt+/+ and Pemt−/− mice treated
with or without PBA (Table 1). Compared to vehicle-treated Pemt+/+
mice, vehicle-treated Pemt−/−mice had higher plasma levels of the che-
motactic chemokines IP-10, MCP-1 and MIG, but lower levels of the
anti-inﬂammatory cytokines IL-2, IL-9, IL-12 and IL-15. Cytokines im-
portant for an immune response, such as eotaxin, IFNγ, KC and MIP1α
and VEGF (important for angiogenesis), were also lower in vehicle-
treated Pemt−/− mice compared to Pemt+/+ mice. Overall, levels of
macrophage attractant chemokines were higher in Pemt−/−mice than
in Pemt+/+ mice, whereas levels of anti-inﬂammatory ILs were lower.
PBA reduced IL-7 and IL-12 (p40) in Pemt+/+ mice. In Pemt−/− mice,
PBA increased eotaxin, but decreased RANTES. These data show that
PBA has only a minor impact on levels of cytokines and chemokines in
livers of mice of both Pemt genotypes.4. Discussion
Wereport for theﬁrst time that the PC/PEmolar ratio in hepatic ER is
lower in chow-fed Pemt−/− mice than in Pemt+/+ mice, and that the
Pemt−/−mice exhibit hepatic ER stress. Similarly, expression of PEMT
in McA cells, which lack PEMT activity, increases the PC/PE ratio and
prevents activation of the UPR and ER stress. We speculate that pre-
existing ER stress in livers of chow-fed Pemt−/−mice promotes the de-
velopment of HF diet-induced NASH. The chemical chaperone, PBA,
modestly reduces hepatic TG accumulation in HF-fed Pemt−/− mice
but does not attenuate ER stress or suppress the development of
NASH in these mice. In addition, PBA alleviates ER stress, but does not
prevent activation of the UPR caused by PEMT deﬁciency in McA cells.
4.1. Aberrant ER phospholipid composition is associated with ER stress
The composition of membrane lipids is a known regulator of ER
stress. For example, increased incorporation of the saturated fatty acid,
palmitate, into ER lipids induces ER stress in cells [38]. In contrast, poly-
unsaturated fatty acids suppress ER stress [39]. Our data show that even
in chow-fed mice, the lack of PEMT reduces the molar ratio of PC/PE in
hepatic ER coincident with the induction of ER stress, but does not in-
crease hepatic TG content (Fig. 1A) [11]. Thus, TG accumulation is un-
likely to be the primary trigger for this type of hepatic ER stress. The
PC content and PC/PE ratio in the hepatic ER were lower in both
chow-fed and HF-fed Pemt−/− mice than in Pemt+/+ mice (Figs. 1F
and 2C). Similarly, introduction of PEMT into McA hepatoma cells
Table 1
Hepatic cytokines and chemokines levels in Veh- and PBA-treated mice. Pemt−/− and
Pemt+/+ mice were fed the HF diet for 2 weeks concurrently with treatment with vehicle
(Veh) or PBA. Levels of cytokines and chemokines were measured in livers of 4–6 mice in
each group. Data are means (pg/mg protein) ± SEM. *P b 0.05 for Pemt−/−vs Pemt+/+
mice with the same treatment; #P b 0.05 for Veh-treated vs PBA-treated mice of the same
genotype.
Treatment Veh PBA
Pemt genotype Pemt+/+ Pemt−/− Pemt+/+ Pemt−/−
Eotaxin 18.4 ± 0.69 9.69 ± 0.9* 17.7 ± 1.34 13.0 ± 0.83*#
IFNγ 5.68 ± 0.57 1.87 ± 0.1* 5.0 ± 0.73 1.54 ± 0.3*
IL-1α 29.2 ± 0.95 26.31 ± 1.58 29.13 ± 1.24 16.1 ± 4.49*
IL-1β 8.12 ± 0.91 3.44 ± 1.82 4.58 ± 1.74 4.97 ± 0.7
IL-2 14.5 ± 0.65 7.16 ± 1.13* 12.5 ± 0.43 8.83 ± 0.42*
IL-4 0.26 ± 0.02 0.51 ± 0.15 0.21 ± 0.01 0.26 ± 0.02
IL-5 0.15 ± 0.03 0.01 ± 0.01* 0.05 ± 0.03 0.04 ± 0.02
IL-6 1.87 ± 0.18 1.34 ± 0.34* 1.4 ± 0.08 1.48 ± 0.16
IL-7 9.45 ± 0.9 6.27 ± 1.17 6.29 ± 0.65# 5.76 ± 0.56
IL-9 35.9 ± 0.59 17.6 ± 2.9* 35.8 ± 4.37 18.1 ± 0.8*
IL-10 4.79 ± 1.46 2.67 ± 0.75 3.18 ± 0.43 1.43 ± 0.2*
IL-12 (p40) 26.2 ± 1.17 8.35 ± 4.42* 20.0 ± 0.99# 3.22 ± 1.41*
IL-12 (p70) 6.49 ± 5.05 11.3 ± 5.68 1.23 ± 0.21 4.59 ± 3.21
IL-15 25.5 ± 4.51 1.52 ± 0.39* 18.7 ± 5.4 2.44 ± 0.45*
IP-10 8.87 ± 0.32 19.8 ± 1.29* 8.63 ± 1.06 23.8 ± 2.33*
KC 57.5 ± 5.43 35.5 ± 6.06* 83.1 ± 17.25 42.2 ± 1.86
LIF 0.54 ± 0.13 0.43 ± 0.14 0.25 ± 0.07 0.48 ± 0.06
LIX 2.66 ± 1.09 2.76 ± 1.47 1.94 ± 1.58 3.01 ± 1.78
MCP-1 13.1±2.24 39.6 ± 5.95* 8.98 ± 1.69 33.4 ± 2.2*
M-CSF 3.12 ± 0.84 0.97 ± 0.08 1.26 ± 0.23 0.97 ± 0.28
MIG 33.1 ± 4.44 87.5 ± 12.72* 41.6 ± 12.77 51.6 ± 4.92
MIP-1α 18.6 ± 1.08 9.15 ± 0.84* 16.9 ± 0.85 10.7 ± 0.42*
MIP-2 15.2 ± 4.97 7.15 ± 1.34 9.82 ± 1.89 7.97 ± 2.53
RANTES 4.99 ± 0.3 5.21 ± 0.35 5.44 ± 1.81 4.00 ± 0.16#
TNFα 2.98 ± 0.84 0.55 ± 0 2.15 ± 0.22 1.01 ± 0.37*
VEGF 1.01 ± 0.08 0.68 ± 0.09* 0.83 ± 0.06 0.88 ± 0.05
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PE molar ratio and suppressed ER stress (Fig. 3). Therefore, our data in-
dicate that PEMT deﬁciency might induce hepatic ER stress by altering
the PC and PE content, and/or the PC/PE ratio, of the ER.
There are some differences between our study and a recent report
on ob/ob mice [34] in which the PC/PE ratio in hepatic ER was higher
than in the control lean mice, possibly because both the CDP-choline
and PEMT pathways for PC synthesis were stimulated in ob/ob mice
[34]. In both chow-fed and HF-fed Pemt−/− mice, the PC/PE ratio in
the ER is lower than in Pemt+/+ mice (Figs. 1F and 2C and [7]). Even
in chow-fed mice that exhibited only minor steatosis, PEMT deﬁciency
caused hepatic ER stress (Fig. 1). In contrast, reducing PEMT activity in
ob/obmice coincided with a normalized hepatic PC/PE ratio, resulting
in a reduction of hepatic TG and ER stress [34]. The difference between
these two studies might be explained, at least in part, by the triggering
of distinct mechanisms for induction of ER stress in the different mouse
models. In ob/ob mice, hepatic fat accumulation promoted ER stress.
However, in chow-fed Pemt−/−mice, the amounts of hepatic TG, cho-
lesterol and cholesteryl esters are very low compared to those in HF-
fed Pemt−/−mice or ob/obmice [12,40]. Furthermore, absolute values
for the PC/PE ratio in the ER were different in the two studies, perhaps
due to different methodologies for ER isolation and lipid analyses [34].
In ob/ob mice the average PC/PE ratio was 1.97 compared to 1.30 for
lean mice. In contrast, in the present study, the hepatic PC/PE ratio in
the ER was 2.59 ± 0.13 in chow-fed Pemt+/+ mice and 1.58 ± 0.08 in
chow-fed Pemt−/− mice. When the mice were challenged with a HF
diet in our study, the PC/PE ratio in the hepatic ER from Pemt+/+ mice
was 2.14 ± 0.06 and in Pemt−/− mice was 1. ± 0.11. Taken together,
it appears that an aberrant PC/PE ratio, either increased or decreased be-
yond a certain threshold, might promote ER stress.
Recently, Hotamisligil's group reported that a consistently enhanced
physical association between the ER and mitochondria in ob/ob mice
caused mitochondrial dysfunction [41]. However, contradictory results
have been reported elsewhere [42]. In other studies from our lab, theabsence of PEMT in primarymousehepatocytes, changedmitochondrial
morphology and increased mitochondrial respiration and ATP produc-
tion [29]. These data suggest, therefore, that the morphological and
functional changes that occur in mitochondria of Pemt−/−mice might
be, at least in part, a consequence of increased ER stress and/or a de-
creased PC/PE ratio.
4.2. PBA alleviates steatosis but not NASH in HF-fed Pemt−/−mice
PBA is an FDA-approved drug used for treatment of urea cycle disor-
ders and sickle cell disease [43]. PBA is a small chemical chaperone that
stabilizes protein conformation and increases folding capacity of ER pro-
teins and has been reported to reduce ER stress [36,43]. Induction of he-
patic ER stress has been associated with obesity in several types of
genetically-alteredmice and dietary models in mice [15]. Oral ingestion
of PBA completely restored insulin signaling and glucose homeostasis in
ob/obmice, and reduced hepatic lipid accumulation and ER stress [36].
PBA also alleviated ischemia/reperfusion injury to the liver in mice by
reducing ER stress and apoptosis [43]. Moreover, pre-treatment of
mice with PBA reduced oleate-mediated ER stress [44]. On the basis of
these observations, we treated HF-fed Pemt−/− mice with PBA [36].
PBA slightly, but signiﬁcantly, reduced hepatic TG accumulation but
did not alleviate ER stress, nor did PBA prevent inﬂammation, ﬁbrosis
or NASHprogression (Figs. 5 and 6). PBA also reduced apoptotic features
in HF-fed Pemt−/− mice, supported by reduced protein levels of cyto-
chrome c and cleaved-caspase 3, and Tunel staining of liver sections
(Fig. 7). This alleviated apoptosis possibly reﬂects a secondary effect of
reduced hepatic TG accumulation in these mice. Since hepatic ER stress
in HF-fed Pemt−/− mice was not improved by PBA, we speculate that
this ER stress is independent of ongoing apoptosis in these mouse livers
lacking PEMT. Similar to ourmodel,mice fed amethionine- and choline-
deﬁcient diet also exhibited hepatic ER stress [45,46]. PBA alleviated the
ER stress in these mice, but did not reverse NASH [47], although the
small dosage of PBA (1/5 of that used in our study) might have dimin-
ished its efﬁcacy.
In summary, the major novel ﬁnding of the current studies is that
PEMT deﬁciency reduces the amount of PC in hepatic ER and disrupts
the balance between PC and PE. Moreover, Pemt−/− mice exhibit ER
stress without activation of the UPR and in the absence of TG accumula-
tion. In addition, pre-existing hepatic ER stress renders chow-fed
Pemt−/− mice prone to the development of HF diet-induced NASH. In
the McA hepatoma cell model, PEMT deﬁciency increases ER stress
and activates the UPR, both of which changes are reversed by PEMT ex-
pression. Although PEMT deﬁciency reduces the PC/PE ratio in hepatic
ER and induces ER stress, our studies do not necessarily link the reduc-
tion in the PC/PE ratio of the ER directly to the induction of ER stress. An
alternative scenario might be that PEMT deﬁciency alters the hepatic
PC/PE ratio in the ER and independently causes ER stress.
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